Publication | Closed Access

Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseCoronary Artery DiseaseCardiovascular PharmacologyIntracoronary NitroprussidePharmacotherapyAcute Myocardial InfarctionNo-reflow PhenomenonMedicineCardiologyEmergency MedicineAnesthesiologyMyocardial Infarction